This association between XPA expression and cisplatin response observed in patient samples was also detected in GCT cell lines, highlighting the potential of XPA as a biomarker for both chemo-resistance and disease severity in GCTs (Cierna et al., 2020). Here, XPA is linked to granular cell tumor.